Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALIGN: Sarilumab in Ankylosing Spondylitis
NCT01061723Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2010
- Primary completion
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 14
01
Overview
A Phase 2 trial of sarilumab in ankylosing spondylitis (AS), sponsored by Sanofi. Started Feb 2010; status: completed.
02
Drugs
sarilumab
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT01061723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01061723.